Vaccinia Virus Expressing Interferon Regulatory Factor 3 Induces Higher Protective Immune Responses against Lethal Poxvirus Challenge in Atopic Organism
Vaccinia virus (VACV) is an enveloped DNA virus from the Orthopoxvirus family, various strains of which were used in the successful eradication campaign against smallpox. Both original and newer VACV-based replicating vaccines reveal a risk of serious complications in atopic individuals. VACV encode...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539567/ https://www.ncbi.nlm.nih.gov/pubmed/34696416 http://dx.doi.org/10.3390/v13101986 |
_version_ | 1784588778241785856 |
---|---|
author | Pilna, Hana Hajkova, Vera Knitlova, Jarmila Liskova, Jana Elsterova, Jana Melkova, Zora |
author_facet | Pilna, Hana Hajkova, Vera Knitlova, Jarmila Liskova, Jana Elsterova, Jana Melkova, Zora |
author_sort | Pilna, Hana |
collection | PubMed |
description | Vaccinia virus (VACV) is an enveloped DNA virus from the Orthopoxvirus family, various strains of which were used in the successful eradication campaign against smallpox. Both original and newer VACV-based replicating vaccines reveal a risk of serious complications in atopic individuals. VACV encodes various factors interfering with host immune responses at multiple levels. In atopic skin, the production of type I interferon is compromised, while VACV specifically inhibits the phosphorylation of the Interferon Regulatory Factor 3 (IRF-3) and expression of interferons. To overcome this block, we generated a recombinant VACV-expressing murine IRF-3 (WR-IRF3) and characterized its effects on virus growth, cytokine expression and apoptosis in tissue cultures and in spontaneously atopic Nc/Nga and control Balb/c mice. Further, we explored the induction of protective immune responses against a lethal dose of wild-type WR, the surrogate of smallpox. We demonstrate that the overexpression of IRF-3 by WR-IRF3 increases the expression of type I interferon, modulates the expression of several cytokines and induces superior protective immune responses against a lethal poxvirus challenge in both Nc/Nga and Balb/c mice. Additionally, the results may be informative for design of other virus-based vaccines or for therapy of different viral infections. |
format | Online Article Text |
id | pubmed-8539567 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85395672021-10-24 Vaccinia Virus Expressing Interferon Regulatory Factor 3 Induces Higher Protective Immune Responses against Lethal Poxvirus Challenge in Atopic Organism Pilna, Hana Hajkova, Vera Knitlova, Jarmila Liskova, Jana Elsterova, Jana Melkova, Zora Viruses Article Vaccinia virus (VACV) is an enveloped DNA virus from the Orthopoxvirus family, various strains of which were used in the successful eradication campaign against smallpox. Both original and newer VACV-based replicating vaccines reveal a risk of serious complications in atopic individuals. VACV encodes various factors interfering with host immune responses at multiple levels. In atopic skin, the production of type I interferon is compromised, while VACV specifically inhibits the phosphorylation of the Interferon Regulatory Factor 3 (IRF-3) and expression of interferons. To overcome this block, we generated a recombinant VACV-expressing murine IRF-3 (WR-IRF3) and characterized its effects on virus growth, cytokine expression and apoptosis in tissue cultures and in spontaneously atopic Nc/Nga and control Balb/c mice. Further, we explored the induction of protective immune responses against a lethal dose of wild-type WR, the surrogate of smallpox. We demonstrate that the overexpression of IRF-3 by WR-IRF3 increases the expression of type I interferon, modulates the expression of several cytokines and induces superior protective immune responses against a lethal poxvirus challenge in both Nc/Nga and Balb/c mice. Additionally, the results may be informative for design of other virus-based vaccines or for therapy of different viral infections. MDPI 2021-10-03 /pmc/articles/PMC8539567/ /pubmed/34696416 http://dx.doi.org/10.3390/v13101986 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pilna, Hana Hajkova, Vera Knitlova, Jarmila Liskova, Jana Elsterova, Jana Melkova, Zora Vaccinia Virus Expressing Interferon Regulatory Factor 3 Induces Higher Protective Immune Responses against Lethal Poxvirus Challenge in Atopic Organism |
title | Vaccinia Virus Expressing Interferon Regulatory Factor 3 Induces Higher Protective Immune Responses against Lethal Poxvirus Challenge in Atopic Organism |
title_full | Vaccinia Virus Expressing Interferon Regulatory Factor 3 Induces Higher Protective Immune Responses against Lethal Poxvirus Challenge in Atopic Organism |
title_fullStr | Vaccinia Virus Expressing Interferon Regulatory Factor 3 Induces Higher Protective Immune Responses against Lethal Poxvirus Challenge in Atopic Organism |
title_full_unstemmed | Vaccinia Virus Expressing Interferon Regulatory Factor 3 Induces Higher Protective Immune Responses against Lethal Poxvirus Challenge in Atopic Organism |
title_short | Vaccinia Virus Expressing Interferon Regulatory Factor 3 Induces Higher Protective Immune Responses against Lethal Poxvirus Challenge in Atopic Organism |
title_sort | vaccinia virus expressing interferon regulatory factor 3 induces higher protective immune responses against lethal poxvirus challenge in atopic organism |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539567/ https://www.ncbi.nlm.nih.gov/pubmed/34696416 http://dx.doi.org/10.3390/v13101986 |
work_keys_str_mv | AT pilnahana vacciniavirusexpressinginterferonregulatoryfactor3induceshigherprotectiveimmuneresponsesagainstlethalpoxviruschallengeinatopicorganism AT hajkovavera vacciniavirusexpressinginterferonregulatoryfactor3induceshigherprotectiveimmuneresponsesagainstlethalpoxviruschallengeinatopicorganism AT knitlovajarmila vacciniavirusexpressinginterferonregulatoryfactor3induceshigherprotectiveimmuneresponsesagainstlethalpoxviruschallengeinatopicorganism AT liskovajana vacciniavirusexpressinginterferonregulatoryfactor3induceshigherprotectiveimmuneresponsesagainstlethalpoxviruschallengeinatopicorganism AT elsterovajana vacciniavirusexpressinginterferonregulatoryfactor3induceshigherprotectiveimmuneresponsesagainstlethalpoxviruschallengeinatopicorganism AT melkovazora vacciniavirusexpressinginterferonregulatoryfactor3induceshigherprotectiveimmuneresponsesagainstlethalpoxviruschallengeinatopicorganism |